El código SA/NC 3002 se considera fuera del ámbito para la preparación EUDR.
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products El motor de ámbito indexado devuelve Out of scope para este código. No Annex I scope match was found for this indexed CN code.
Por qué esta página de referencia da esa respuesta.
- Descripción del código
- Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products
- Base en el anexo I
- Sin entrada directa en el anexo I
- Base de la fuente
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Filas superiores, inferiores y próximas.
La vista de biblioteca es para la navegación de referencia. Use el comprobador cuando quiera ejecutar otro código como acción.
30productos farmacéuticosout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout300211malaria diagnostic test kitsout300212antisera and other blood fractionsout300213immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleout300214immunological products, mixed, not put up in measured doses or in forms or packings for retail saleout300215immunological products, put up in measured doses or in forms or packings for retail saleout300219immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive)out300220vaccines for human medicineout300230vaccines for veterinary medicineout300231foot-and-mouth vaccinesout3001dried glands and other organs for organo-therapeutic uses, whether or not powdered; extracts of glands or other organs or their secretions, for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, n.e.s.out3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out3004medicaments consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. goods of heading 3002, 3005 or 3006)out3005wadding, gauze, bandages and the like, e.g. dressings, adhesive plasters, poultices, impregnated or covered with pharmaceutical substances or put up for retail sale for medical, surgical, dental or veterinary purposesout3006pharmaceutical preparations and products of subheadings 3006.10.10 to 3006.60.90out
Qué significa esto para la preparación.
Esta fila no activa directamente la recogida de pruebas en el resultado de ámbito actual.
Regulation (EU) 2023/1115 Annex I — relevant productsconsultado el 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115consultado el 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)consultado el 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)consultado el 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8consultado el 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingconsultado el 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradersconsultado el 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)consultado el 2026-08-08